These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 29476029)

  • 1. OpenPrescribing: normalised data and software tool to research trends in English NHS primary care prescribing 1998-2016.
    Curtis HJ; Goldacre B
    BMJ Open; 2018 Feb; 8(2):e019921. PubMed ID: 29476029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New mechanism to identify cost savings in English NHS prescribing: minimising 'price per unit', a cross-sectional study.
    Croker R; Walker AJ; Bacon S; Curtis HJ; French L; Goldacre B
    BMJ Open; 2018 Feb; 8(2):e019643. PubMed ID: 29439078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends and variation in prescribing of low-priority treatments identified by NHS England: a cross-sectional study and interactive data tool in English primary care.
    Walker AJ; Curtis HJ; Bacon S; Croker R; Goldacre B
    J R Soc Med; 2018 Jun; 111(6):203-213. PubMed ID: 29787684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measuring the Impact of an Open Web-Based Prescribing Data Analysis Service on Clinical Practice: Cohort Study on NHS England Data.
    Walker AJ; Curtis HJ; Croker R; Bacon S; Goldacre B
    J Med Internet Res; 2019 Jan; 21(1):e10929. PubMed ID: 30664459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential savings from generic prescribing and generic substitution in South Africa.
    Karim SS; Pillai G; Ziqubu-Page TT; Cassimjee MH; Morar MS
    Health Policy Plan; 1996 Jun; 11(2):198-205. PubMed ID: 10158460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do doctors in dispensing practices with a financial conflict of interest prescribe more expensive drugs? A cross-sectional analysis of English primary care prescribing data.
    Goldacre B; Reynolds C; Powell-Smith A; Walker AJ; Yates TA; Croker R; Smeeth L
    BMJ Open; 2019 Feb; 9(2):e026886. PubMed ID: 30813120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. UK interventions to control medicines wastage: a critical review.
    White KG
    Int J Pharm Pract; 2010 Jun; 18(3):131-40. PubMed ID: 20509346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinician impact and financial cost to the NHS of litigation over pregabalin: a cohort study in English primary care.
    Croker R; Smyth D; Walker AJ; Goldacre B
    BMJ Open; 2018 Jun; 8(6):e022416. PubMed ID: 29880577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of body mass index on prescribing costs and potential cost savings of a weight management programme in primary care.
    Counterweight Project Team
    J Health Serv Res Policy; 2008 Jul; 13(3):158-66. PubMed ID: 18573765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suboptimal prescribing behaviour associated with clinical software design features: a retrospective cohort study in English NHS primary care.
    MacKenna B; Curtis HJ; Walker AJ; Bacon S; Croker R; Goldacre B
    Br J Gen Pract; 2020 Sep; 70(698):e636-e643. PubMed ID: 32784218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Web-based survey to assess the perceptions of managed care organization representatives on use of copay subsidy coupons for prescription drugs.
    Nemlekar P; Shepherd M; Lawson K; Rush S
    J Manag Care Pharm; 2013 Oct; 19(8):602-8. PubMed ID: 24074006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of fundholding and indicative prescribing schemes on general practitioners' prescribing costs.
    Bradlow J; Coulter A
    BMJ; 1993 Nov; 307(6913):1186-9. PubMed ID: 8251847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rates and pillage.
    Moore A
    Health Serv J; 2002 Dec; 112(5834):10-1. PubMed ID: 12500593
    [No Abstract]   [Full Text] [Related]  

  • 14. Potential savings from substituting generic drugs for brand-name drugs: medical expenditure panel survey, 1997-2000.
    Haas JS; Phillips KA; Gerstenberger EP; Seger AC
    Ann Intern Med; 2005 Jun; 142(11):891-7. PubMed ID: 15941695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medicines management. Fit to bust.
    Calvert R
    Health Serv J; 2002 Oct; 112(5826):24-5. PubMed ID: 12397667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of the 'Better Care Better Value' prescribing policy on the utilisation of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for treating hypertension in the UK primary care setting: longitudinal quasi-experimental design.
    Baker A; Chen LC; Elliott RA; Godman B
    BMC Health Serv Res; 2015 Sep; 15():367. PubMed ID: 26359265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PrAna: an R package to calculate and visualize England NHS primary care prescribing data.
    Jagadeesan KK; Grant J; Griffin S; Barden R; Kasprzyk-Hordern B
    BMC Med Inform Decis Mak; 2022 Jan; 22(1):5. PubMed ID: 34991567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 10-year trends in English primary care glaucoma prescribing.
    Hogg HDJ; Connor A
    Eye (Lond); 2020 Jan; 34(1):192-196. PubMed ID: 31685974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of managerial intervention on drug utilization pattern at King Chulalongkorn Memorial Hospital.
    Limpanasithikul W; Wangsaturaka D; Nantawan P; Itthipanichapong C; Thamaree S; Wittayalertpanya S; Ketcharoen A; Taworn N; Kemsri W; Kusolsomboon T; Tangphao O
    J Med Assoc Thai; 2002 Jun; 85 Suppl 1():S336-43. PubMed ID: 12188432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug formularies--good or evil? A view using prescribing analyses and cost trends data.
    Chapman S
    Cardiology; 1994; 85 Suppl 1():46-53. PubMed ID: 7743535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.